PALO ALTO, Calif. (AP) ¿ Varian Medical Systems Inc., which makes cancer therapy systems, said Thursday its fiscal fourth-quarter profit jumped 23.5 percent on a boost from sales cancer therapy systems. The company earned $97 million, or 77 cents per share, up from profit of $78.5 million, or 62 cents per share, during the same period a year ago. Revenue rose 8 percent to $642 million from $592.7 million. The fiscal 2009 fourth-quarter ended Sept. 30. Analysts polled by Thomson Reuters expected profit of 74 cents per share on revenue of $593.2 million. Revenue in the oncology systems segment rose 9 percent to $527 million. X-ray product revenue rose 11 percent to $93 million. Looking ahead, the company said it expects profit from continuing operations between $2.65 and $2.75 per share in fiscal 2010 on up to a 5 percent boost in revenue. Shares of Varian closed at $42.22 Thursday.
More from Technology
Slack Stock Is Worth Picking Up, MKM Partners Analyst Says
Analyst Rohit Kulkarni initiates the San Francisco parent of the collaboration app at buy with a $40 price target, indicating 30% upside potential from Wednesday's close.
SolarEdge Shares Dim on Founder's Leave for Health Reasons
Solar-energy-tech provider's shares drop amid UBS stock downgrade and news that the founder and CEO has taken a leave of absence for a health issue.
Synopsys Gains After Earnings Beat by Chip-Design-Software Maker
It is the third time in the past four quarters that Synopsys has beat analyst estimates.
WeWork's $47B Valuation Draws Critics, 'Tepid' Demand on Secondary Markets
Skeptics say WeWork's $47 billion private valuation suggests it's viewed as a tech company when it's something closer to a commercial real estate firm.